Evidence map›Paper›PMID 42282512›Full record

ArticlebioRxiv : the preprint server for biology2026

Histone succinylation directly inhibits Jumonji domain demethylases and stabilizes repressive chromatin states.

Sarah Graff, Stephanie Stransky, Isaac Kraz, Kheerthana Duraivelan, Alexander Poppel, Adam Chatoff, Nathaniel W Snyder, Scott Garforth, David Shechter, Juan Pablo Maianti and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sarah GraffDepartment of Biochemistry, Albert Einstein College of Medicine, New York, NY, USA.ORCID 0000-0002-4999-5454
Stephanie StranskyDepartment of Biochemistry, Albert Einstein College of Medicine, New York, NY, USA.ORCID 0000-0003-0844-2754
Isaac KrazDepartment of Biochemistry, Albert Einstein College of Medicine, New York, NY, USA.
Kheerthana DuraivelanDepartment of Biochemistry, Albert Einstein College of Medicine, New York, NY, USA.
Alexander PoppelDepartment of Biochemistry, Albert Einstein College of Medicine, New York, NY, USA.
Adam ChatoffAging + Cardiovascular Discovery Center, Department of Cardiovascular Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
Nathaniel W SnyderAging + Cardiovascular Discovery Center, Department of Cardiovascular Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.ORCID 0000-0001-5643-8747
Scott GarforthDepartment of Biochemistry, Albert Einstein College of Medicine, New York, NY, USA.
David ShechterDepartment of Biochemistry, Albert Einstein College of Medicine, New York, NY, USA.
Juan Pablo MaiantiDepartment of Biochemistry, Albert Einstein College of Medicine, New York, NY, USA.
Simone SidoliDepartment of Biochemistry, Albert Einstein College of Medicine, New York, NY, USA.ORCID 0000-0001-9073-6641

Funding

Research Project 4: Mining human antibody responses to inform vaccine and therapeutic designU19AI181977 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI Jimmy D Gollihar · 2024 to 2026
$56.1M
Medical Scientist Training ProgramT32GM149364 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI Myles H. Akabas · 2023 to 2026
$7.5M
Integrative Cardiovascular PathophysiologyT32HL091804 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI ELROD, JOHN WILLIAM · 2008 to 2024
$4.5M
PRMT5-MEP50 Histone Arginine Methylation in Early DevelopmentR01GM108646 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SHECHTER, DAVID · 2014 to 2022
$3.2M
Orbitrap Exploris 480 Basic SystemS10OD030286 · OD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI SIDOLI, SIMONE · 2021 to 2021
$600k
Measuring compartmentalized metabolism of cofactorsR35GM156596 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI Nathaniel W. Snyder · 2025 to 2026
$555k
NHLBI NIH HHS T32 HL091804NIAID NIH HHS U19 AI181977NIGMS NIH HHS R01 GM108646NIGMS NIH HHS R35 GM156596NIGMS NIH HHS T32 GM149364NIH HHS S10 OD030286
6 · The paper itself

Abstract

Herein we uncover a relationship between histone succinylation and Jumonji (JmjC) domain-containing histone demethylases. We used quantitative proteomics and peptide pull-down assays to identify JmjC demethylases as candidate interactors with succinylated histone peptides. Succinyl-lysine peptides bind and inhibit the catalytic activity of JmjC demethylases in a dose-dependent manner. This includes KDM4D and KDM6B, which are responsible for the removal of the silencing marks H3K9me2/3 and H3K27me2/3. Supraphysiological sodium succinate treatment of HepG2/C3A cells increased the relative abundance of histone succinylation, H3K9me2/3, and H3K27me2/3. CUT&Tag and ChIP-mass spectrometry revealed the co-occurrence of succinylation with these repressive methylation marks, in addition to reduced transcriptional output. This work establishes a novel mechanistic link between metabolite abundance and chromatin regulation and suggests a role for histone succinylation in the maintenance of heterochromatin.

Indexed as

heterochromatinhistone succinylationJumonji demethylasesKDM4DKDM6BLC-MS proteomics

Identifiers

PMID42282512
PMCPMC13252378

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.